OVATION SCIENCE INC. Ovation Science Inc. Share Price OTC Markets
Equities
OVATF
CA69016D1087
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0278 USD | -18.38% |
|
-18.24% | +7.34% |
| 05-29 | Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-07 | Ovation Science Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2022 | 138K 101K 7.98M | Sales 2023 | 61.93K 45.2K 3.58M | Capitalization | 1.19M 866K 68.5M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | 5.4 x |
| Net Debt 2022 | 12.23K 8.93K 706K | Net Debt 2023 | 144K 105K 8.3M | EV / Sales 2023 | 21.5 x |
| P/E ratio 2022 |
-0.92
x | P/E ratio 2023 |
-1.31
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.07% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -18.38% | ||
| 1 week | -18.24% | ||
| Current month | -30.50% | ||
| 1 month | -30.50% | ||
| 3 months | -25.07% | ||
| 6 months | -17.51% | ||
| Current year | +7.34% |
1 month
0.03
0.03
Current year
0.030.04
1 year
0.000.12
3 years
0.000.13
5 years
0.000.41
10 years
0.000.48
| Managers | Title | Age | Since |
|---|---|---|---|
Doreen McMorran
FOU | Founder | 61 | 17/07/17 |
Terry Howlett
FOU | Founder | 75 | 17/07/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Terry Howlett
FOU | Founder | 75 | 17/07/17 |
Doreen McMorran
FOU | Founder | 61 | 17/07/17 |
Joan Chypyha
BRD | Director/Board Member | 57 | 01/02/18 |
Ovation Science Inc. is a Canada-based research and development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. It manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skin care products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers health and wellness products enhanced with hemp-derived CBD and delivered by patented Invisicare skin technology.
Calendar
21/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -22.92% | 985M | |
| -14.04% | 134M | |
| -21.75% | 57.16M | |
| +2.03% | 57.07M |
- Stock Market
- Equities
- OVAT Stock
- OVATF Stock
